Sistemsko zdravljenje napredovalega medularnega karcinoma ščitnice
Systemic treatment of advanced medullary thyroid carcinoma

Authors

  • Cvetka Grašič-Kuhar Onkološki inštitut, Ljubljana

Keywords:

medullary thyroid cancer, thyroid cancer, systemic treatment, advanced cancer, medullary thyroid carcinoma

Abstract

Medularni karcinom ščitnice nastane iz nevroendokrinih celic ščitnice, ki izločajo kalcitonin. Kalcitonin je specifičen marker medularnega raka ščitnice. Pri lokalno napredovalem ali metastaskem medularnem raku ščitnice ob simptomtskem progresu prihaja v poštev zdravljenje s tirozin kinaznimi inhibitorji. Registrirani substanci sta vandetanib in cabozantinib, učinkoviti pa sta tudi sorafenib in sunitinib. Izbira zdravljenja je individualizirana glede na breme bolezni in spremljajoče bolezni. Zelo pomembno je tudi podporno (na simptome usmerjeno) zdravljenje. ; slv - slovenski


Abstract (Eng)

Medullary thyroid carcinoma originates from neuroendocrine cells of the thyroid which secrete calcitonin. Calcitonin is a specific marker for medullary thyroid cancer. Therapy with tyrosine kinase inhibitors can be applied to treat locally advanced or metastatic medullary thyroid cancer with progressing symptoms. Registered substances used are vandetanib and cabozantinib, and sorafenib and sunitinib are also effective. Treatment is determined individually based on the burden of the cancer and secondary diseases. Supportive treatment (targeted at the symptoms) is also very important.

Downloads

Published

2016-06-15

How to Cite

Grašič-Kuhar, C. (2016). Systemic treatment of advanced medullary thyroid carcinoma. Onkologija : Slovenian Journal of Oncology, 20(1), 4–6. Retrieved from https://revijaonkologija.si/Onkologija/article/view/66

Issue

Vol. 20 No. 1 (2016)

Section

Review Article

License

The journal is published under the terms of the Creative Commons Attribution License CC-BY 4.0. The authors retain the copyright to their work without any restrictions whatsoever.

This journal is an open-access journal, meaning that all of its contents are freely accessible without any charge to the user or their institution. In accordance with the Budapest Open Access Initiative (BOAI) definition of open access, users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author, provided the authors and the journal are appropriately credited.